Latest Diabetes: Type II news
GLP-1 Receptor Agonist Use Linked to Chronic Cough Among Adults With Type 2 Diabetes
posted December 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
AI Diabetes Prevention Program Yields Similar Results as Human-Led Program
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
AHA: GLP-1 Receptor Agonists Not Linked to Pancreatitis in Adults With High Triglycerides
posted November 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure
Weight-Loss Surgery Produces Lasting Diabetes Remission
Study IDs Real-World Reasons for Lemborexant Discontinuation
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors